Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

Cited In for PubMed (Select 17395784)

1.

Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.

Li JM, Giver CR, Lu Y, Hossain MS, Akhtari M, Waller EK.

Immunotherapy. 2009 Jul;1(4):599-621. Review.

2.

Gas6 deficiency in recipient mice of allogeneic transplantation alleviates hepatic graft-versus-host disease.

Burnier L, Saller F, Kadi L, Brisset AC, Sugamele R, Baudino L, Bono F, Herbert JM, Carmeliet P, Schapira M, Izui S, Angelillo-Scherrer A.

Blood. 2010 Apr 22;115(16):3390-7. doi: 10.1182/blood-2009-02-206920. Epub 2010 Feb 4.

3.

The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.

Na IK, Lu SX, Yim NL, Goldberg GL, Tsai J, Rao U, Smith OM, King CG, Suh D, Hirschhorn-Cymerman D, Palomba L, Penack O, Holland AM, Jenq RR, Ghosh A, Tran H, Merghoub T, Liu C, Sempowski GD, Ventevogel M, Beauchemin N, van den Brink MR.

J Clin Invest. 2010 Jan;120(1):343-56. doi: 10.1172/JCI39395. Epub 2009 Dec 1.

4.

IL-17 contributes to CD4-mediated graft-versus-host disease.

Kappel LW, Goldberg GL, King CG, Suh DY, Smith OM, Ligh C, Holland AM, Grubin J, Mark NM, Liu C, Iwakura Y, Heller G, van den Brink MR.

Blood. 2009 Jan 22;113(4):945-52. doi: 10.1182/blood-2008-08-172155. Epub 2008 Oct 17.

5.

Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.

Yi T, Zhao D, Lin CL, Zhang C, Chen Y, Todorov I, LeBon T, Kandeel F, Forman S, Zeng D.

Blood. 2008 Sep 1;112(5):2101-10. doi: 10.1182/blood-2007-12-126987. Epub 2008 Jul 2.

6.

Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients.

Kitko CL, Paczesny S, Yanik G, Braun T, Jones D, Whitfield J, Choi SW, Hutchinson RJ, Ferrara JL, Levine JE.

Biol Blood Marrow Transplant. 2008 Jul;14(7):759-65. doi: 10.1016/j.bbmt.2008.04.002.

7.

Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease.

Levine JE, Paczesny S, Mineishi S, Braun T, Choi SW, Hutchinson RJ, Jones D, Khaled Y, Kitko CL, Bickley D, Krijanovski O, Reddy P, Yanik G, Ferrara JL.

Blood. 2008 Feb 15;111(4):2470-5. Epub 2007 Nov 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk